CEFOTETAN DISODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for cefotetan disodium and what is the scope of patent protection?
Cefotetan disodium
is the generic ingredient in four branded drugs marketed by Pai Holdings Pharm, Teligent, Fresenius Kabi Usa, Hikma, West-ward Pharm Corp, and B Braun, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.Three suppliers are listed for this compound.
Summary for CEFOTETAN DISODIUM
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 6 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 43 |
| Clinical Trials: | 1 |
| Drug Prices: | Drug price trends for CEFOTETAN DISODIUM |
| What excipients (inactive ingredients) are in CEFOTETAN DISODIUM? | CEFOTETAN DISODIUM excipients list |
| DailyMed Link: | CEFOTETAN DISODIUM at DailyMed |
Recent Clinical Trials for CEFOTETAN DISODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
| Federal University of São Paulo | Phase 4 |
Pharmacology for CEFOTETAN DISODIUM
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEFOTETAN DISODIUM
Anatomical Therapeutic Chemical (ATC) Classes for CEFOTETAN DISODIUM
US Patents and Regulatory Information for CEFOTETAN DISODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | CEFOTETAN | cefotetan disodium | INJECTABLE;INJECTION | 065375-001 | Aug 9, 2007 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | CEFOTETAN | cefotetan disodium | INJECTABLE;INJECTION | 065374-001 | Aug 9, 2007 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| B Braun | CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER | cefotetan disodium | INJECTABLE;INJECTION | 065430-001 | Aug 9, 2007 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch